Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Investing can seem daunting for beginners. Understand the essential concepts to kickstart your investment journey.
17,710 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Two popular healthcare ETFs, PJP and XBI, offer very different paths to exposure. This guide breaks down the trade-of...
Investors looking at cannabis real estate need to understand how Innovative Industrial Properties reports earnings. T...
As Zymeworks gears up for 2026 earnings, investors should focus on cash runway, pipeline milestones, and collaboratio...
AI investing can take two paths: a targeted, actively managed approach with CHAT or a broad, low-cost tech track with...
Two popular healthcare ETFs—IHE and IBB—offer very different routes to exposure: established pharma vs biotech innova...
SoundHound AI is testing a high-growth path in voice commerce and Vision AI. This article explains why some investors...
In 2025, a surprising shift reshaped the starter-home landscape: flippers supplied more starter homes than traditiona...
OpenAI confronts multi-front pressure as its largest backer rethinks bets, Microsoft shifts workloads inward, and riv...
When a CEO buys thousands of shares, investors take note. This article breaks down the 74,000-share purchase by Energ...
Even after severe bear markets, stocks tend to bounce back. This article breaks down the evidence, shares concrete ex...
For investors seeking steady income, certain dividend stocks worth more today offer reliable payouts and potential pr...